A summary of daily biopharma industry news regarding the novel coronavirus trending on March 27, 2020, with the FDA now working with 220 test developers.
San Francisco-based Vir Biotechnology indicated the company identified several human monoclonal antibody (mAb) candidates against SARS-CoV-2, the virus causing COVID-19.
The U.S. Food and Drug Administration provided Emergency Use Authorization (EUA) for the PerkinElmer Inc.’s New Coronavirus RT-PCR test.
New York will launch a clinical trial using blood plasma from patients who have recovered from COVID-19, the disease caused by the novel coronavirus.
